<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38002386</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2306-5354</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>11</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>30</Day></PubDate></JournalIssue><Title>Bioengineering (Basel, Switzerland)</Title><ISOAbbreviation>Bioengineering (Basel)</ISOAbbreviation></Journal><ArticleTitle>Anti-COVID-19, Anti-Inflammatory, and Anti-Osteoarthritis Activities of Sesamin from <i>Sesamum indicum</i> L.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1263</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/bioengineering10111263</ELocationID><Abstract><AbstractText>During the COVID-19 (coronavirus disease 2019) outbreak, many people were infected, and the symptoms may persist for several weeks or months for recovering patients. This is also known as "long COVID" and includes symptoms such as fatigue, joint pain, muscle pain, et cetera. The COVID-19 virus may trigger hyper-inflammation associated with cytokine levels in the body. COVID-19 can trigger inflammation in the joints, which can lead to osteoarthritis (OA), while long-term COVID-19 symptoms may lead to joint damage and other inflammation problems. According to several studies, sesame has potent anti-inflammatory properties due to its major constituent, sesamin. This study examined sesamin's anti-inflammatory, anti-osteoarthritis, and anti-COVID-19 effects. Moreover, in vivo and in vitro assays were used to determine sesamin's anti-inflammatory activity against the RAW264.7 and SW1353 cell lines. Sesamin had a dose-dependent effect (20 mg/kg) in a monoiodoacetic acid (MIA)-induced osteoarthritis rat model. Sesamin reduced paw swelling and joint discomfort. In addition, the findings indicated that sesamin suppressed the expression of iNOS (inducible nitric oxide synthase) and COX-2 (cyclooxygenase-2) in the RAW264.7 cell line within the concentration range of 6.25-50 &#x3bc;M. Furthermore, sesamin also had a suppressive effect on MMP (matrix metalloproteinase) expression in chondrocytes and the SW1353 cell line within the same concentration range of 6.25-50 &#x3bc;M. To examine the anti-viral activity, an in silico analysis was performed to evaluate sesamin's binding affinity with SARS-CoV-2 RdRp (severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase) and human ACE2 (angiotensin-converting enzyme 2). Compared to the controls, sesamin exhibited strong binding affinities towards SARS-CoV-2 RdRp and human ACE2. Furthermore, sesamin had a higher binding affinity for the ACE2 target protein. This study suggests that sesamin shows potential anti-SARS-CoV-2 activity for drug development.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Shu-Ming</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Nutrition, College of Medical and Health Care, Hungkuang University, Taichung 433, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nutrition, Nantou Hospital of Ministry of Health and Welfare, Nantou 540, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsieh</LastName><ForeName>Cheng-Yang</ForeName><Initials>CY</Initials><Identifier Source="ORCID">0000-0003-4225-9128</Identifier><AffiliationInfo><Affiliation>Ph.D. Program in Clinical Drug Development of Herbal Medicine, College of Pharmacy, Taipei Medical University, Taipei 110, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Oncology, Pharmacy Practice and Sciences, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai 980-8577, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ting</LastName><ForeName>Jasmine U</ForeName><Initials>JU</Initials><Identifier Source="ORCID">0000-0001-5361-2893</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, College of Science, De La Salle University, Metro Manila 1004, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Castro-Cruz</LastName><ForeName>Kathlia A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>School of Chemical, Biological, and Materials Engineering and Sciences, Map&#xfa;a University, Metro Manila 1002, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ching-Chiung</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Ph.D. Program in Clinical Drug Development of Herbal Medicine, College of Pharmacy, Taipei Medical University, Taipei 110, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Traditional Herbal Medicine Research Center, Taipei Medical University Hospital, Taipei 110, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Institute of Pharmacognosy, College of Pharmacy, Taipei Medical University, Taipei 110, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei 110, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Orthopedics Research Center, Taipei Medical University Hospital, Taipei 110, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Chia-Jung</ForeName><Initials>CJ</Initials><Identifier Source="ORCID">0000-0002-9416-5468</Identifier><AffiliationInfo><Affiliation>Ph.D. Program in Clinical Drug Development of Herbal Medicine, College of Pharmacy, Taipei Medical University, Taipei 110, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Traditional Herbal Medicine Research Center, Taipei Medical University Hospital, Taipei 110, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Institute of Pharmacognosy, College of Pharmacy, Taipei Medical University, Taipei 110, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Po-Wei</ForeName><Initials>PW</Initials><Identifier Source="ORCID">0000-0002-1981-5360</Identifier><AffiliationInfo><Affiliation>Department of Medical Science Industries, College of Health Sciences, Chang Jung Christian University, Tainan 711, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>No. 10821</GrantID><Agency>Taiwan's Ministry of Health and Welfare</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Bioengineering (Basel)</MedlineTA><NlmUniqueID>101676056</NlmUniqueID><ISSNLinking>2306-5354</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2 RdRp</Keyword><Keyword MajorTopicYN="N">anti-COVID-19</Keyword><Keyword MajorTopicYN="N">anti-inflammatory</Keyword><Keyword MajorTopicYN="N">anti-osteoarthritis</Keyword><Keyword MajorTopicYN="N">human ACE2</Keyword><Keyword MajorTopicYN="N">molecular docking</Keyword></KeywordList><CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could appear to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>25</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>25</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>25</Day><Hour>1</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38002386</ArticleId><ArticleId IdType="pmc">PMC10669907</ArticleId><ArticleId IdType="doi">10.3390/bioengineering10111263</ArticleId><ArticleId IdType="pii">bioengineering10111263</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization  Coronavirus Dashboard.  [(accessed on 15 March 2021)].  Available online:  https://covid19.who.int/</Citation></Reference><Reference><Citation>Docherty A.B., Harrison E.M., Green C.A., Hardwick H.E., Pius R., Norman L., Holden K.A., Read J.M., Dondelinger F., Carson G. Features of 20 133 UK Patients in Hospital with Covid-19 Using the ISARIC WHO Clinical Characterisation Protocol: Prospective Observational Cohort Study. bmj. 2020;2020:369. doi: 10.1136/bmj.m1985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1985</ArticleId><ArticleId IdType="pmc">PMC7243036</ArticleId><ArticleId IdType="pubmed">32444460</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran A.V., Jayadevan R., Sashidharan S. Long COVID: An Overview. Diabetes Metab. Syndr. 2021;15:869&#x2013;875. doi: 10.1016/j.dsx.2021.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauwers M., Au M., Yuan S., Wen C. COVID-19 in Joint Ageing and Osteoarthritis: Current Status and Perspectives. Int. J. Mol. Sci. 2022;23:720. doi: 10.3390/ijms23020720.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23020720</ArticleId><ArticleId IdType="pmc">PMC8775477</ArticleId><ArticleId IdType="pubmed">35054906</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong A.Y.S., MacKenna B., Morton C.E., Schultze A., Walker A.J., Bhaskaran K., Brown J.P., Rentsch C.T., Williamson E., Drysdale H. Use of Non-Steroidal Anti-Inflammatory Drugs and Risk of Death from COVID-19: An OpenSAFELY Cohort Analysis Based on Two Cohorts. Ann. Rheum. Dis. 2021;80:943&#x2013;951. doi: 10.1136/annrheumdis-2020-219517.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-219517</ArticleId><ArticleId IdType="pmc">PMC7823433</ArticleId><ArticleId IdType="pubmed">33478953</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewanjee S., Kandimalla R., Kalra R.S., Valupadas C., Vallamkondu J., Kolli V., Dey Ray S., Reddy A.P., Reddy P.H. COVID-19 and Rheumatoid Arthritis Crosstalk: Emerging Association, Therapeutic Options and Challenges. Cells. 2021;10:291. doi: 10.3390/cells10123291.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10123291</ArticleId><ArticleId IdType="pmc">PMC8699554</ArticleId><ArticleId IdType="pubmed">34943795</ArticleId></ArticleIdList></Reference><Reference><Citation>Quicke J.G., Conaghan P.G., Corp N., Peat G. Osteoarthritis Year in Review 2021: Epidemiology &amp; Therapy. Osteoarthr. Cartil. 2021;30:196&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pubmed">34695571</ArticleId></ArticleIdList></Reference><Reference><Citation>Castiglione G.M., Zhou L., Xu Z., Neiman Z., Hung C.-F., Duh E.J. Evolutionary Pathways to SARS-CoV-2 Resistance Are Opened and Closed by Epistasis Acting on ACE2. PLoS Biol. 2021;19:e3001510. doi: 10.1371/journal.pbio.3001510.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3001510</ArticleId><ArticleId IdType="pmc">PMC8730403</ArticleId><ArticleId IdType="pubmed">34932561</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Kleine-Weber H., Schroeder S., Kr&#xfc;ger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.-H., Nitsche A. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181:271&#x2013;280. doi: 10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou P., Yang X.-L., Wang X.-G., Hu B., Zhang L., Zhang W., Si H.-R., Zhu Y., Li B., Huang C.-L. A Pneumonia Outbreak Associated with a New Coronavirus of Probable Bat Origin. Nature. 2020;579:270&#x2013;273. doi: 10.1038/s41586-020-2012-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2012-7</ArticleId><ArticleId IdType="pmc">PMC7095418</ArticleId><ArticleId IdType="pubmed">32015507</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpagnano G.E., Di Lecce V., Quaranta V.N., Zito A., Buonamico E., Capozza E., Palumbo A., Di Gioia G., Valerio V.N., Resta O. Vitamin D Deficiency as a Predictor of Poor Prognosis in Patients with Acute Respiratory Failure Due to COVID-19. J. Endocrinol. Investig. 2021;44:765&#x2013;771. doi: 10.1007/s40618-020-01370-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-020-01370-x</ArticleId><ArticleId IdType="pmc">PMC7415009</ArticleId><ArticleId IdType="pubmed">32772324</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadizadeh F. Supplementation with Vitamin D in the COVID-19 Pandemic? Nutr. Rev. 2021;79:200&#x2013;208. doi: 10.1093/nutrit/nuaa081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nutrit/nuaa081</ArticleId><ArticleId IdType="pmc">PMC7454793</ArticleId><ArticleId IdType="pubmed">32679589</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar R., Rathi H., Haq A., Wimalawansa S.J., Sharma A. Putative Roles of Vitamin D in Modulating Immune Response and Immunopathology Associated with COVID-19. Virus Res. 2021;292:198235. doi: 10.1016/j.virusres.2020.198235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2020.198235</ArticleId><ArticleId IdType="pmc">PMC7680047</ArticleId><ArticleId IdType="pubmed">33232783</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffith J.F. Musculoskeletal Complications of Severe Acute Respiratory Syndrome. Semin. Musculoskelet. Radiol. 2011;15:554&#x2013;560. doi: 10.1055/s-0031-1293500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0031-1293500</ArticleId><ArticleId IdType="pubmed">22081289</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuzun S., Keles A., Okutan D., Yildiran T., Palamar D. Assessment of musculoskeletal pain, fatigue and grip strength in hospitalized patients with COVID-19. Eur. J. Phys. Rehabil. Med. 2021;57:653&#x2013;662. doi: 10.23736/S1973-9087.20.06563-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S1973-9087.20.06563-6</ArticleId><ArticleId IdType="pubmed">33393277</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C., Rodr&#xed;guez-Jim&#xe9;nez J., Fuensalida-Novo S., Palacios-Ce&#xf1;a M., G&#xf3;mez-Mayordomo V., Florencio L.L., Hern&#xe1;ndez-Barrera V., Arendt-Nielsen L. Myalgia as a Symptom at Hospital Admission by Severe Acute Respiratory Syndrome Coronavirus 2 Infection Is Associated with Persistent Musculoskeletal Pain as Long-Term Post-COVID Sequelae: A Case-Control Study. Pain. 2021;162:2832&#x2013;2840. doi: 10.1097/j.pain.0000000000002306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002306</ArticleId><ArticleId IdType="pubmed">33863864</ArticleId></ArticleIdList></Reference><Reference><Citation>Tosato M., Carf&#xec; A., Martis I., Pais C., Ciciarello F., Rota E., Tritto M., Salerno A., Zazzara M.B., Martone A.M. Prevalence and Predictors of Persistence of COVID-19 Symptoms in Older Adults: A Single-Center Study. J. Am. Med. Dir. Assoc. 2021;22:1840&#x2013;1844. doi: 10.1016/j.jamda.2021.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2021.07.003</ArticleId><ArticleId IdType="pmc">PMC8286874</ArticleId><ArticleId IdType="pubmed">34352201</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi O.L., Hughes S.E., Turner G., Rivera S.C., McMullan C., Chandan J.S., Haroon S., Price G., Davies E.H., Nirantharakumar K. Symptoms, Complications and Management of Long COVID: A Review. J. R. Soc. Med. 2021;114:428&#x2013;442. doi: 10.1177/01410768211032850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Vehar S., Boushra M., Ntiamoah P., Biehl M. Post-Acute Sequelae of SARS-CoV-2 Infection: Caring for the &#x2018;Long-Haulers. &#x2019; Cleve Clin. J. Med. 2021;88:267&#x2013;272. doi: 10.3949/ccjm.88a.21010.</Citation><ArticleIdList><ArticleId IdType="doi">10.3949/ccjm.88a.21010</ArticleId><ArticleId IdType="pubmed">33941600</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenberg J.H., Rai V., Dilisio M.F., Agrawal D.K. Damage-Associated Molecular Patterns in the Pathogenesis of Osteoarthritis: Potentially Novel Therapeutic Targets. Mol. Cell Biochem. 2017;434:171&#x2013;179. doi: 10.1007/s11010-017-3047-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11010-017-3047-4</ArticleId><ArticleId IdType="pmc">PMC5671379</ArticleId><ArticleId IdType="pubmed">28474284</ArticleId></ArticleIdList></Reference><Reference><Citation>Sokolove J., Lepus C.M. Role of Inflammation in the Pathogenesis of Osteoarthritis: Latest Findings and Interpretations. Ther. Adv. Musculoskelet. Dis. 2013;5:77&#x2013;94. doi: 10.1177/1759720X12467868.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1759720X12467868</ArticleId><ArticleId IdType="pmc">PMC3638313</ArticleId><ArticleId IdType="pubmed">23641259</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayami T., Pickarski M., Zhuo Y., Wesolowski G.A., Rodan G.A., Duong L.E.T. Characterization of Articular Cartilage and Subchondral Bone Changes in the Rat Anterior Cruciate Ligament Transection and Meniscectomized Models of Osteoarthritis. Bone. 2006;38:234&#x2013;243. doi: 10.1016/j.bone.2005.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bone.2005.08.007</ArticleId><ArticleId IdType="pubmed">16185945</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearle A.D., Warren R.F., Rodeo S.A. Basic Science of Articular Cartilage and Osteoarthritis. Clin. Sports Med. 2005;24:1&#x2013;12. doi: 10.1016/j.csm.2004.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.csm.2004.08.007</ArticleId><ArticleId IdType="pubmed">15636773</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldring M.B. Osteoarthritis and Cartilage: The Role of Cytokines. Curr. Rheumatol. Rep. 2000;2:459&#x2013;465. doi: 10.1007/s11926-000-0021-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11926-000-0021-y</ArticleId><ArticleId IdType="pubmed">11123098</ArticleId></ArticleIdList></Reference><Reference><Citation>Rietschel E.T., Kirikae T., Schade F.U., Mamat U., Schmidt G., Loppnow H., Ulmer A.J., Z&#xe4;hringer U., Seydel U., di Padova F. Bacterial Endotoxin: Molecular Relationships of Structure to Activity and Function. FASEB J. 1994;8:217&#x2013;225. doi: 10.1096/fasebj.8.2.8119492.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fasebj.8.2.8119492</ArticleId><ArticleId IdType="pubmed">8119492</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng A.W.M., Stabler T.V., Bolognesi M., Kraus V.B. Selenomethionine Inhibits IL-1&#x3b2; Inducible Nitric Oxide Synthase (INOS) and Cyclooxygenase 2 (COX2) Expression in Primary Human Chondrocytes. Osteoarthr. Cartil. 2011;19:118&#x2013;125. doi: 10.1016/j.joca.2010.10.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joca.2010.10.019</ArticleId><ArticleId IdType="pmc">PMC3053078</ArticleId><ArticleId IdType="pubmed">21035557</ArticleId></ArticleIdList></Reference><Reference><Citation>Daheshia M., Yao J.Q. The Interleukin 1&#x3b2; Pathway in the Pathogenesis of Osteoarthritis. J. Rheumatol. 2008;35:2306&#x2013;2312. doi: 10.3899/jrheum.080346.</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.080346</ArticleId><ArticleId IdType="pubmed">18925684</ArticleId></ArticleIdList></Reference><Reference><Citation>Struglics A., Larsson S., Pratta M.A., Kumar S., Lark M.W., Lohmander L.S. Human Osteoarthritis Synovial Fluid and Joint Cartilage Contain Both Aggrecanase-and Matrix Metalloproteinase-Generated Aggrecan Fragments. Osteoarthr. Cartil. 2006;14:101&#x2013;113. doi: 10.1016/j.joca.2005.07.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joca.2005.07.018</ArticleId><ArticleId IdType="pubmed">16188468</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell P.G., Magna H.A., Reeves L.M., Lopresti-Morrow L.L., Yocum S.A., Rosner P.J., Geoghegan K.F., Hambor J.E. Cloning, Expression, and Type II Collagenolytic Activity of Matrix Metalloproteinase-13 from Human Osteoarthritic Cartilage. J. Clin. Investig. 1996;97:761&#x2013;768. doi: 10.1172/JCI118475.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI118475</ArticleId><ArticleId IdType="pmc">PMC507114</ArticleId><ArticleId IdType="pubmed">8609233</ArticleId></ArticleIdList></Reference><Reference><Citation>Grougnet R., Magiatis P., Laborie H., Lazarou D., Papadopoulos A., Skaltsounis A.-L. Sesamolinol Glucoside, Disaminyl Ether, and Other Lignans from Sesame Seeds. J. Agric. Food Chem. 2012;60:108&#x2013;111. doi: 10.1021/jf2040687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jf2040687</ArticleId><ArticleId IdType="pubmed">22148167</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad N., Sanjay K.R., Prasad D.S., Vijay N., Kothari R. Nutrition &amp; Food. J. Nutr. 2012;2:1000127.</Citation></Reference><Reference><Citation>Anilakumar K.R., Pal A., Khanum F., Bawa A.S. Nutritional, Medicinal and Industrial Uses of Sesame (Sesamum Indicum L.) Seeds-an Overview. Agric. Conspec. Sci. 2010;75:159&#x2013;168.</Citation></Reference><Reference><Citation>Mukta N., Neeta P.M. A Review on Sesame-an Ethno Medicinally Significant Oil Crop. Int. J. Life Sci. Pharma Res. 2017;7:L58&#x2013;L63.</Citation></Reference><Reference><Citation>Bedigian D. History and Lore of Sesame in Southwest Asia. Econ. Bot. 2004;58:329&#x2013;353. doi: 10.1663/0013-0001(2004)058[0330:HALOSI]2.0.CO;2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1663/0013-0001(2004)058[0330:HALOSI]2.0.CO;2</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedigian D., Harlan J.R. Evidence for Cultivation of Sesame in the Ancient World. Econ. Bot. 1986;40:137&#x2013;154. doi: 10.1007/BF02859136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02859136</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan M.S., Raj S.K., Snehi S.K. first report of&#x2019;candidatus phytoplasma asteris&#x2019;affecting sesame cultivation in india. J. Plant Pathol. 2007;89:301.</Citation></Reference><Reference><Citation>Saydut A., Duz M.Z., Kaya C., Kafadar A.B., Hamamci C. Transesterified Sesame (Sesamum Indicum L.) Seed Oil as a Biodiesel Fuel. Bioresour. Technol. 2008;99:6656&#x2013;6660. doi: 10.1016/j.biortech.2007.11.063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biortech.2007.11.063</ArticleId><ArticleId IdType="pubmed">18178427</ArticleId></ArticleIdList></Reference><Reference><Citation>Moazzami A.A. Sesame Seed Lignans Diversity, Human Metabolism and Bioactivities. Swedish University of Agricultural Sciences; Uppsala, Sweden: 2006.</Citation></Reference><Reference><Citation>Pathak N., Rai A.K., Kumari R., Bhat K. v Value Addition in Sesame: A Perspective on Bioactive Components for Enhancing Utility and Profitability. Pharmacogn. Rev. 2014;8:147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4127822</ArticleId><ArticleId IdType="pubmed">25125886</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwertner H.A., Rios D.C. Analysis of Sesamin, Asarinin, and Sesamolin by HPLC with Photodiode and Fluorescent Detection and by GC/MS: Application to Sesame Oil and Serum Samples. J. Am. Oil Chem. Soc. 2012;89:1943&#x2013;1950. doi: 10.1007/s11746-012-2098-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11746-012-2098-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Saleem T.S.M., Basha S.D., Mahesh G., Rani P.V.S., Kumar N.S., Chetty C.M. Analgesic, Anti-Pyretic and Anti-Inflammatory Activity of Dietary Sesame Oil in Experimental Animal Models. Pharmacologia. 2011;2:172&#x2013;177. doi: 10.5567/pharmacologia.2011.172.177.</Citation><ArticleIdList><ArticleId IdType="doi">10.5567/pharmacologia.2011.172.177</ArticleId></ArticleIdList></Reference><Reference><Citation>Periasamy S., Chien S.-P., Chang P.-C., Hsu D.-Z., Liu M.-Y. Sesame Oil Mitigates Nutritional Steatohepatitis via Attenuation of Oxidative Stress and Inflammation: A Tale of Two-Hit Hypothesis. J. Nutr. Biochem. 2014;25:232&#x2013;240. doi: 10.1016/j.jnutbio.2013.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnutbio.2013.10.013</ArticleId><ArticleId IdType="pubmed">24445049</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C.-T., Liu M.-Y. Daily Sesame Oil Supplementation Attenuates Local Renin-Angiotensin System via Inhibiting MAPK Activation and Oxidative Stress in Cardiac Hypertrophy. J. Nutr. Biochem. 2017;42:108&#x2013;116. doi: 10.1016/j.jnutbio.2016.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnutbio.2016.05.006</ArticleId><ArticleId IdType="pubmed">28160636</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan J., Ge J., Yu J., Shan S., Zhou H., Fan S., Zhang Q., Shi X., Wang Q., Zhang L., et al. Structure of the SARS-CoV-2 Spike Receptor-Binding Domain Bound to the ACE2 Receptor. Nature. 2020;581:215&#x2013;220. doi: 10.1038/s41586-020-2180-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2180-5</ArticleId><ArticleId IdType="pubmed">32225176</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Boyle N.M., Banck M., James C.A., Morley C., Vandermeersch T., Hutchison G.R. Open Babel: An Open Chemical Toolbox. J. Cheminform. 2011;3:33. doi: 10.1186/1758-2946-3-33.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1758-2946-3-33</ArticleId><ArticleId IdType="pmc">PMC3198950</ArticleId><ArticleId IdType="pubmed">21982300</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizvi S.M.D., Shakil S., Haneef M. A Simple Click by Click Protocol to Perform Docking: AutoDock 4.2 Made Easy for Non-Bioinformaticians. EXCLI J. 2013;12:831.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4669947</ArticleId><ArticleId IdType="pubmed">26648810</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson R.J., Weng Z., Campbell R.K., Jiang X. Main-chain Conformational Tendencies of Amino Acids. Proteins Struct. Funct. Bioinform. 2005;60:679&#x2013;689. doi: 10.1002/prot.20530.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prot.20530</ArticleId><ArticleId IdType="pubmed">16021632</ArticleId></ArticleIdList></Reference><Reference><Citation>Doharey P.K., Singh V., Gedda M.R., Sahoo A.K., Varadwaj P.K., Sharma B. In Silico Study Indicates Antimalarials as Direct Inhibitors of SARS-CoV-2-RNA Dependent RNA Polymerase. J. Biomol. Struct. Dyn. 2022;40:5588&#x2013;5605. doi: 10.1080/07391102.2021.1871956.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07391102.2021.1871956</ArticleId><ArticleId IdType="pmc">PMC7842134</ArticleId><ArticleId IdType="pubmed">33475021</ArticleId></ArticleIdList></Reference><Reference><Citation>Eweas A.F., Alhossary A.A., Abdel-Moneim A.S. Molecular Docking Reveals Ivermectin and Remdesivir as Potential Repurposed Drugs against SARS-CoV-2. Front. Microbiol. 2021;2021:3602. doi: 10.3389/fmicb.2020.592908.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.592908</ArticleId><ArticleId IdType="pmc">PMC7976659</ArticleId><ArticleId IdType="pubmed">33746908</ArticleId></ArticleIdList></Reference><Reference><Citation>Trott O., Olson A.J. AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading. J. Comput. Chem. 2010;31:455&#x2013;461. doi: 10.1002/jcc.21334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcc.21334</ArticleId><ArticleId IdType="pmc">PMC3041641</ArticleId><ArticleId IdType="pubmed">19499576</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuriata A., Gierut A.M., Oleniecki T., Ciemny M.P., Kolinski A., Kurcinski M., Kmiecik S. CABS-Flex 2.0: A Web Server for Fast Simulations of Flexibility of Protein Structures. Nucleic Acids Res. 2018;46:W338&#x2013;W343. doi: 10.1093/nar/gky356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky356</ArticleId><ArticleId IdType="pmc">PMC6031000</ArticleId><ArticleId IdType="pubmed">29762700</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneidman-Duhovny D., Dror O., Inbar Y., Nussinov R., Wolfson H.J. PharmaGist: A Webserver for Ligand-Based Pharmacophore Detection. Nucleic Acids Res. 2008;36:W223&#x2013;W228. doi: 10.1093/nar/gkn187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkn187</ArticleId><ArticleId IdType="pmc">PMC2447755</ArticleId><ArticleId IdType="pubmed">18424800</ArticleId></ArticleIdList></Reference><Reference><Citation>Barratt E., Bingham R.J., Warner D.J., Laughton C.A., Phillips S.E.V., Homans S.W. Van Der Waals Interactions Dominate Ligand&#x2212; Protein Association in a Protein Binding Site Occluded from Solvent Water. J. Am. Chem. Soc. 2005;127:11827&#x2013;11834. doi: 10.1021/ja0527525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ja0527525</ArticleId><ArticleId IdType="pubmed">16104761</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer E.A., Castellano R.K., Diederich F. Interactions with Aromatic Rings in Chemical and Biological Recognition. Angew. Chem. Int. Ed. 2003;42:1210&#x2013;1250. doi: 10.1002/anie.200390319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.200390319</ArticleId><ArticleId IdType="pubmed">12645054</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J.-F., Wang M.-Y., Wang D., Li J.-Y., Hao G.-F., Li Q.X., Yang G.-F. A Comprehensive Analysis of Protein Data Bank Reveals Low Desolvation Penalty in &#x3c0;-Cation System. Chem. Biol. 2020 in press .</Citation></Reference><Reference><Citation>Hubbard R.E., Haider M.K. Hydrogen Bonds in Proteins: Role and Strength. eLS. 2010;2010:112.</Citation></Reference><Reference><Citation>Raschka S., Wolf A.J., Bemister-Buffington J., Kuhn L.A. Protein&#x2013;Ligand Interfaces Are Polarized: Discovery of a Strong Trend for Intermolecular Hydrogen Bonds to Favor Donors on the Protein Side with Implications for Predicting and Designing Ligand Complexes. J. Comput. Aided Mol. Des. 2018;32:511&#x2013;528. doi: 10.1007/s10822-018-0105-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10822-018-0105-2</ArticleId><ArticleId IdType="pubmed">29435780</ArticleId></ArticleIdList></Reference><Reference><Citation>Bravo J.P.K., Dangerfield T.L., Taylor D.W., Johnson K.A. Remdesivir Is a Delayed Translocation Inhibitor of SARS-CoV-2 Replication. Mol. Cell. 2021;81:1548&#x2013;1552. doi: 10.1016/j.molcel.2021.01.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2021.01.035</ArticleId><ArticleId IdType="pmc">PMC7843106</ArticleId><ArticleId IdType="pubmed">33631104</ArticleId></ArticleIdList></Reference><Reference><Citation>Gim&#xe9;nez B.G., Santos M.S., Ferrarini M., Fernandes J.P.S. Evaluation of Blockbuster Drugs under the Rule-of-Five. Pharm. Int. J. Pharm. Sci. 2010;65:148&#x2013;152.</Citation><ArticleIdList><ArticleId IdType="pubmed">20225662</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Y., Li C., Liu G., Liu R., Chen Y., Li W., Cao Z., Zhao B., Lu C., Liu Y. Drug-Metabolizing Cytochrome P450 Enzymes Have Multifarious Influences on Treatment Outcomes. Clin. Pharmacokinet. 2021;60:585&#x2013;601. doi: 10.1007/s40262-021-01001-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40262-021-01001-5</ArticleId><ArticleId IdType="pubmed">33723723</ArticleId></ArticleIdList></Reference><Reference><Citation>Doherty M.M., Pang K.S. First-Pass Effect: Significance of the Intestine for Absorption and Metabolism. Drug Chem. Toxicol. 1997;20:329&#x2013;344. doi: 10.3109/01480549709003891.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/01480549709003891</ArticleId><ArticleId IdType="pubmed">9433662</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackman R.L. Phosphoramidate Prodrugs Continue to Deliver, The Journey of Remdesivir (GS-5734) from RSV to SARS-CoV-2. ACS Med. Chem. Lett. 2022;13:338&#x2013;347. doi: 10.1021/acsmedchemlett.1c00624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsmedchemlett.1c00624</ArticleId><ArticleId IdType="pmc">PMC8887656</ArticleId><ArticleId IdType="pubmed">35291757</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeedi-Boroujeni A., Mahmoudian-Sani M., Bahadoram M., Alghasi A. COVID-19: A Case for Inhibiting NLRP3 Inflammasome, Suppression of Inflammation with Curcumin? Basic Clin. Pharmacol. Toxicol. 2021;128:37&#x2013;45. doi: 10.1111/bcpt.13503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bcpt.13503</ArticleId><ArticleId IdType="pubmed">33099890</ArticleId></ArticleIdList></Reference><Reference><Citation>Fara A., Mitrev Z., Rosalia R.A., Assas B.M. Cytokine Storm and COVID-19: A Chronicle of pro-Inflammatory Cytokines. Open Biol. 2020;10:200160. doi: 10.1098/rsob.200160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsob.200160</ArticleId><ArticleId IdType="pmc">PMC7536084</ArticleId><ArticleId IdType="pubmed">32961074</ArticleId></ArticleIdList></Reference><Reference><Citation>Salom&#xe3;o R., Assis V., de Sousa Neto I.V., Petriz B., Babault N., Durigan J.L.Q., de C&#xe1;ssia Marqueti R. Involvement of Matrix Metalloproteinases in COVID-19: Molecular Targets, Mechanisms, and Insights for Therapeutic Interventions. Biology. 2023;12:843. doi: 10.3390/biology12060843.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology12060843</ArticleId><ArticleId IdType="pmc">PMC10295079</ArticleId><ArticleId IdType="pubmed">37372128</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelzo M., Cacciapuoti S., Pinchera B., De Rosa A., Cernera G., Scial&#xf2; F., Comegna M., Mormile M., Fabbrocini G., Parrella R., et al. Matrix Metalloproteinases (MMP) 3 and 9 as Biomarkers of Severity in COVID-19 Patients. Sci. Rep. 2022;12:1212. doi: 10.1038/s41598-021-04677-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-04677-8</ArticleId><ArticleId IdType="pmc">PMC8786927</ArticleId><ArticleId IdType="pubmed">35075175</ArticleId></ArticleIdList></Reference><Reference><Citation>Phitak T., Pothacharoen P., Settakorn J., Poompimol W., Caterson B., Kongtawelert P. Chondroprotective and Anti-Inflammatory Effects of Sesamin. Phytochemistry. 2012;80:77&#x2013;88. doi: 10.1016/j.phytochem.2012.05.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phytochem.2012.05.016</ArticleId><ArticleId IdType="pubmed">22704650</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong P., Chen G., Jiang A., Wang Y., Song C., Zhuang J., Xi C., Wang G., Ji Y., Yan J. Sesamin Inhibits IL-1&#x3b2;-Stimulated Inflammatory Response in Human Osteoarthritis Chondrocytes by Activating Nrf2 Signaling Pathway. Oncotarget. 2016;7:83720. doi: 10.18632/oncotarget.13360.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.13360</ArticleId><ArticleId IdType="pmc">PMC5347798</ArticleId><ArticleId IdType="pubmed">27863411</ArticleId></ArticleIdList></Reference><Reference><Citation>Towler P., Staker B., Prasad S.G., Menon S., Tang J., Parsons T., Ryan D., Fisher M., Williams D., Dales N.A. ACE2 X-Ray Structures Reveal a Large Hinge-Bending Motion Important for Inhibitor Binding and Catalysis. J. Biol. Chem. 2004;279:17996&#x2013;18007. doi: 10.1074/jbc.M311191200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M311191200</ArticleId><ArticleId IdType="pmc">PMC7980034</ArticleId><ArticleId IdType="pubmed">14754895</ArticleId></ArticleIdList></Reference><Reference><Citation>Vangeel L., Chiu W., De Jonghe S., Maes P., Slechten B., Raymenants J., Andr&#xe9; E., Leyssen P., Neyts J., Jochmans D. Remdesivir, Molnupiravir and Nirmatrelvir Remain Active against SARS-CoV-2 Omicron and Other Variants of Concern. Antivir. Res. 2022;198:105252. doi: 10.1016/j.antiviral.2022.105252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2022.105252</ArticleId><ArticleId IdType="pmc">PMC8785409</ArticleId><ArticleId IdType="pubmed">35085683</ArticleId></ArticleIdList></Reference><Reference><Citation>Takashita E., Yamayoshi S., Simon V., van Bakel H., Sordillo E.M., Pekosz A., Fukushi S., Suzuki T., Maeda K., Halfmann P., et al. Efficacy of Antibodies and Anti-viral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants. N. Engl. J. Med. 2022;387:468&#x2013;470. doi: 10.1056/NEJMc2207519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2207519</ArticleId><ArticleId IdType="pmc">PMC9342381</ArticleId><ArticleId IdType="pubmed">35857646</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad I., Pawara R., Surana S., Patel H. The Repurposed ACE2 Inhibitors: SARS-CoV-2 Entry Blockers of COVID-19. Top. Curr. Chem. 2021;379:40. doi: 10.1007/s41061-021-00353-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s41061-021-00353-7</ArticleId><ArticleId IdType="pmc">PMC8498772</ArticleId><ArticleId IdType="pubmed">34623536</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>